sis of apoptotic cells ( Figure 1A ). The production of the combinant mTGF-␤ and IL-10 strongly suppressed IL-12 p70 production stimulated by IFN-␥ and LPS, use of anti-inflammatory cytokine IL-10 ( Figure 1B ) and prostaglandin E 2 (PGE 2 ) ( Figure 1C ) was not significantly alneutralizing antibodies to TGF-␤ and IL-10 had no impact on apoptotic cell-induced inhibition of IL-12. Neutered, whereas TGF-␤1 production ( Figure 1D ) was greatly enhanced. To determine if autocrine IL-10 and tralization of the endogenous TGF-␤ was complete, as shown in the ELISA data ( Figure 1H ). These results indi-TGF-␤1 production was responsible for the suppressed IL-12 production, neutralizing antibodies to IL-10 and cate that autocrine IL-10 and TGF-␤ production is not a major player in apoptotic cell-mediated inhibition of TGF-␤1 were added to the macrophage culture in the presence or absence of apoptotic cells. Although the IL-12 synthesis. IL-10 antibody strongly enhanced IL-12 production by activated macrophages, it was not able to restore IL-12
Cell-Cell Contact, Not Phagocytosis, Is Sufficient for Inhibition of IL-12 Production production inhibited by apoptotic cells ( Figure 1E ). Use of a neutralizing antibody to TGF-␤1 resulted in a heteroTo determine if phagocytosis was required for the observed inhibition of IL-12 production by apoptotic cells, geneous response among the six donors tested, with a combined small increase in IL-12 p70 production inhibwe used cytochalasin D (cytoD) to block actin polymerization and prevent phagocytosis without interfering ited by apoptotic cells ( Figure 1F ). To circumvent the problem associated with human subject variations, we with cell-cell contact. Figure 2A shows that the addition of cytoD at increasing concentrations 30 min before performed the same study in the mouse macrophage cell line J774, which has been used extensively as a (Ϫ30 min, triangle) or at the time of addition of apoptotic cells (0 min, square) strongly inhibited the uptake of model system for IL-12-related studies (Murphy et al., 1995). As shown in Figure 1G , although addition of refluorescently labeled apoptotic cells (by ‫.)%78-%07ف‬ Figure 2B shows that at concentrations of 1 and 10 on IL-12 p70 production in primary human macrophages ( Figure 2D ), suggesting that the repressive effect of apo-M cytoD, which suppressed phagocytosis by ‫%08ف‬ (Figure 2A ), IL-12 p40 production by the IFN-␥/LPS-actiptotic cells on IL-12 production could be mediated through the interaction of PS with its receptor(s) on macvated mouse monocytic cell line, RAW264.7, remained completely inhibited following the ingestion of apoptotic rophages. We also determined the effects of the three liposomal cells. This finding indicates that phagocytosis of apoptotic cells is not required to induce the inhibition of ILphospholipids on TGF-␤1 production in RAW264.7 cells ( Figure 2E ). Although PS could induce modest levels 12 p40 production.
PS is a lipid that is exposed on dying cells as an early of TGF-␤1 in IFN-␥/LPS-activated macrophages ‫%06ف(‬ increase over the control), it did not correlate with the sign of apoptotic cell death and serves as a critical recognition molecule on apoptotic cells for clearance by ‫%79ف‬ decrease in IL-12 p40 output. This is consistent with the data presented in Figure 1G , suggesting no phagocytes. PS is considered to be a signaling molecule through its interaction with certain phagocytic receptors major role of the endogenous TGF-␤ in the regulation of IL-12 production by apoptotic cells. GC-BP for its ability to bind to the GC element, GCF. The 619 amino acid sequence of GC-BP predicts end of the p35 promoter (group #2, Ϫ1082/Ϫ4) rendered it totally resistant to the inhibitory effects of apoptotic strongly that it is a zinc finger-containing protein and transcriptional repressor. PSORT II predicts with a very cells. However, two 5Ј deletion constructs (groups #3 and #4) responded to apoptotic cells with the activity high probability and reliability (Ͼ95%) that it is a nuclear protein with 16 putative C2H2-type zinc finger motifs of the full-length construct, thus suggesting that an apoptotic cell response element is located downstream that could interact with DNA ( Figure 5B ). It has a calculated molecular weight of 68.3 kDa. The GC-BP gene of Ϫ4. To further elucidate the precise location of the apoptotic cell response element, we investigated the appears to be unique in the mouse genome and is located on chromosome 7. GC-BP, when expressed in region between Ϫ4 and ϩ61. By computer-assisted sequence analysis, three putative transcription factor recombinant form in a transcription/translation-coupled reaction in rabbit reticulocyte lysates, specifically bound binding sites were identified within this region of the IL-12 p35 promoter: GCF (Kageyama and Pastan, 1989) to the IL-12 p35 promoter GCF site and forms three complexes (marked as I, II, III in Figure 5C , lane 2). The (ϩ13 to ϩ19), CTCF (Klenova et al., 1998) (ϩ4 to ϩ8), and ZEST (Park et al., 1998) (ϩ29 to ϩ34).
binding activities could be completely inhibited by an excess of unlabeled wild-type GCF sequence (W, lane To further delineate the precise response element, mutagenesis by base substitutions was performed to 3), but far less efficiently by the mutant GCF sequence (M, lane 4). The complexes, especially II and III, formed disrupt these three sites. As shown in Figure 4B , mutations of the entire 7 bp GCF site (Construct B), but not with GC-BP could be inhibited by the use of an anti-GC-BP polyclonal Ab that we generated (see the Experithe CTCF and ZEST mutants (data not shown), resulted 
mental Procedures) (lane 6), but not by the control antiderived macrophages (BMDMs) from mice and transduced them with a retrovirus expressing the enhanced serum (lane 5). These data demonstrate the specificity of the GC-BP/GCF interactions and confirm the ability green fluorescent protein (EGFP) or GC-BP plus EGFP (bi-cistronic). The overall transduction efficiency was of recombinant GC-BP, like its endogenous counterpart, to interact with the same sequence element.
‫%05ف‬ as judged by EGFP expression. GC-BP protein overexpression in transduced cells was confirmed by To determine if GC-BP could interact with the endogenous, chromosomal IL-12 p35 gene, we performed chroWestern blot using the polyclonal GC-BP antibody (Figure 6D) . The transduced cells were subjected to cell matin immunoprecipitation (ChIP) assay in RAW264.7 cells by using the polyclonal anti-GC-BP antibody and sorting by FACS to select for EGFP positivity, which yielded the EGFP high and low populations. Then, ILa pair of PCR primers that directed the detection to the region harboring the GCF. As shown in Figure 5D , 12 p40 and p70 production was measured by ELISA. Due to the lack of an IL-12 p35-specific ELISA, and GC-BP-specific binding was strongly and specifically detected in apoptotic cell-treated (lane 11), but not in the fact that IL-12 p70 is composed of p40 and p35 molecules in a 1:1 molar ratio, IL-12 p70 production was untreated (lanes 9 and 10) or necrotic cell-treated, macrophages ( and we showed that these siRNAs could efficiently and specifically block the expression of GC-BP protein in a p35 promoter. Furthermore, GC-BP expression in J774 cells (mouse macrophage) resulted in a selective and dose-dependent manner; cyclin D1 expression, however, was not affected under these conditions ( Figure 6G ). strong inhibition of IL-12 p35 mRNA induction by IFN-␥ and LPS, only marginal inhibition of the p40 mRNA, and Consistently, blocking GC-BP expression in J744 cells by GC-BP-specific siRNAs resulted in a significant reshad no effect on IL-10 (data not shown).
To demonstrate the effect of GC-BP on IL-12 gene toration of IL-12 p35 mRNA expression inhibited by apoptotic cells (compare column 9 to column 7, Figure 6H ), expression in primary cells, we generated bone marrow- while the siRNAs had a slightly enhancing effect on basal Regulation of GC-BP Expression and Tyrosine Phosphorylation mRNA expression (columns 2 and 3) and no effect on IFN-␥/LPS-induced IL-12 p35 mRNA expression (colTo investigate the mode of activation of GC-BP in response to apoptotic cells, we first examined its mRNA umn 6) in the absence of apoptotic cells.
The GC-BP-specific siRNAs caused a dramatic restoexpression, which was found to be constitutively present in macrophage cells regardless of the activation ration of IL-12 p70 production that was totally inhibited following phagocytosis of apoptotic cells (compare colstate of the cell in the presence or absence of apoptotic cells (data not shown). Western blot analysis of GC-BP umn 9 to column 7, Figure 6I ) while having little effect on the IL-12 p40 production (data not shown). Note that in RAW264.7 cells showed that there was no significant difference in the level of GC-BP protein in resting versus IL-12 p70 is composed of p35 and p40 in a 1:1 molar ratio. Although p40 production was not restored, the activated cells, in the nucleus versus the cytoplasm, or in the absence or presence of apoptotic cells added at residual amount of p40 was still considerably higher than the amount of p70 produced. The use of siRNA in two different time points with respect to cell activation by LPS ( Figure 7A ). These data indicate that GC-BP the absence of apoptotic cells with or without LPS did not have any specific impact on IL-12 p70 (columns 2 mRNA or protein expression as well as nuclear localization are not regulated during phagocytosis of apoptotic and 3 and 5 and 6, Figures 6I).
These results confirm that apoptotic cell-induced GCcells, and data suggest that its regulation may involve posttranslational modifications of the protein. BP is a selective inhibitor of IL-12 p35 transcription. As mentioned before, GC-BP has 16 putative zinc whereas a further deletion fragment down to the first 27 amino acids with only one phosphotyrosine motif still finger motifs throughout the protein and two phosphotyrosine motifs at amino acid 15 and 168, respectively. retained ‫%05ف‬ of the repressor activity of GC-BP ( Figure  7B ). This result prompted us to investigate the phosphorTo localize the responsible region for its IL-12 p35-inhibiting activity, we generated a series of C terminus truncaylation status of the endogenous GC-BP by coimmunoprecipiation with phosphotyrosine-specific monoclonal tion constructs of GC-BP. Cotransfection of these truncated GC-BP constructs with IL-12 p35 reporter showed antibodies. As shown in Figure 7C , GC-BP was constitutively tyrosine phosphorylated (lane 1), and its level of that an N-terminal region (the first 198 amino acids) containing the two putative phosphotyrosine motifs rephosphorylation was enhanced in IFN-␥/LPS-stimulated macrophages (lane 2). The increased phosphorylation tained the inhibitory effects of the full-length GC-BP, Here, we provide experimental evidence that signals putative phosphorylation sites of GC-BP, we generated two GC-BP mutants containing a tyrosine-to-phenylaladerived from apoptotic cells, probably through the interaction of the externalized PS with its receptors on nine conversion at amino acid residue 15 (Y15F) or 168 (Y168F) and tested their ability to repress IL-12 p35 phagocytes, induce the novel transcription factor GC-BP that selectively represses IL-12 p35 transcription by promoter activity (Figure 7D) . Interestingly, the Y15F mutant, but not the Y168F mutant, significantly abrogated binding to the GC dinucleotide at ϩ17/ϩ18 of the p35 promoter. Apoptotic cells also potently inhibited IL-12 the inhibitory effect of GC-BP on IL-12 p35 promoter activity. This is consistent with the observation illusp40 protein production. However, the IL-12 p40 mRNA expression was only moderately inhibited by apoptotic trated in Figure 7B We provided clear evidence that GC-BP is modulated by tyrosine phosphorylation in the nucleus ( Figure 7C ).
Macrophage Phagocytosis
Furthermore, mutation studies at the two putative tyro- ological process in which cytokine responses are tightly
